title: Parametric non-mixture cure models for schedule finding of therapeutic agents.
abstract: We propose a phase I clinical trial design that seeks to determine the cumulative safety of a series of administrations of a fixed dose of an investigational agent. In contrast with traditional phase I trials that are designed solely to find the maximum tolerated dose of the agent, our design instead identifies a maximum tolerated schedule that includes a maximum tolerated dose as well as a vector of recommended administration times. Our model is based on a non-mixture cure model that constrains the probability of dose limiting toxicity for all patients to increase monotonically with both dose and the number of administrations received. We assume a specific parametric hazard function for each administration and compute the total hazard of dose limiting toxicity for a schedule as a sum of individual administration hazards. Throughout a variety of settings motivated by an actual study in allogeneic bone marrow transplant recipients, we demonstrate that our approach has excellent operating characteristics and performs as well as the only other currently published design for schedule finding studies. We also present arguments for the preference of our non-mixture cure model over the existing model.
authors: University of Michigan, Ann Arbor, USA.
authors: Changying A
authors: CA
authors: Liu
authors: Thomas M
authors: TM
authors: Braun
references: Biometrics. 2005 Jun;61(2):335-43
references: 16011679
references: Biometrics. 2000 Dec;56(4):1177-82
references: 11129476
references: J Am Stat Assoc. 2003 Dec 1;98(464):1063-1078
references: 21151838
references: Biometrics. 1990 Mar;46(1):33-48
references: 2350571
references: Stat Med. 1995 Jun 15;14(11):1149-61
references: 7667557
references: Stat Med. 2002 Sep 30;21(18):2757-70
references: 12228889
references: Control Clin Trials. 2003 Dec;24(6):669-81
references: 14662273
references: Biometrics. 1996 Jun;52(2):673-84
references: 8672707